IP62-10: Targeting PLXND1 using RNA bioengineering technologies and customized lipid nanoparticles in advanced prostate cancer

Sunday, May 17, 2026 1:00 PM to 3:00 PM · 1 hr. 59 min. (America/New_York)
146A
Abstract

Information

Other
Best Poster

Log in

See all the content and easy-to-use features by logging in or registering!